A significant advance in cancer investigation is occurring with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently inactivated in various types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research